Physician

Wajihuddin Syed

According to 2025 Medicare claims, Wajihuddin Syed (NPI: 1417389099) practices hematology/oncology in the Elgin, IL market, with the plurality of this provider's patient population coming from Kane, IL. This provider's primary affiliated billing organization is NORTHWEST ONCOLOGY AND HEMATOLOGY SC (NPI: 1225099427; TIN: 363395596) and primary practice location at 60169-5036. Syed is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Syed's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 280 traditional Medicare patients, billed 32,537 HCPCS/CPT codes, and received $453,238 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 183 prescription claims across 48 beneficiaries totaling $649,244 in drug costs, led by Xtandi (Enzalutamide). 2020 DME data shows 75 claims. Open Payments data shows 38 records totaling $903. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,959 to $453,238. Similarly, Part D prescription costs have risen steadily, from $2,781 to $649,244. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	57	72	$5,959
2020	335	767	$59,152
2021	212	653	$54,307
2022	242	7,182	$134,008
2023	198	4,212	$94,130
2024	280	32,537	$453,238

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	16	56	$2,781
2016	15	85	$4,006
2017	27	67	$86,918
2018	25	79	$60,867
2019	24	48	$52,277
2020	123	578	$772,673
2021	123	489	$1,065,904
2022	57	203	$483,952
2023	29	91	$152,444
2024	48	183	$649,244

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	75	$2,713
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	78	81	$140
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	83	193	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	48	61	$83
80053	Blood test, comprehensive group of blood chemicals	63	138	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	105	256	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	11	330	$151,918
Xarelto	Rivaroxaban	19	1,020	$19,529
Letrozole	Letrozole	18	1,440	$321
Hydrocortisone	Hydrocortisone	12	360	$178
Ondansetron Hcl	Ondansetron Hcl	12	236	$81

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$903	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Wajihuddin Syed?

Tedicare shows public-source Medicare data for Wajihuddin Syed (NPI 1417389099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wajihuddin Syed have ACO affiliation data?

Wajihuddin Syed is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Wajihuddin Syed?

Wajihuddin Syed is linked to NORTHWEST ONCOLOGY AND HEMATOLOGY SC (billing NPI 1225099427) in the available physician profile data.

Does Wajihuddin Syed have Open Payments data?

Wajihuddin Syed has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.